FMP

FMP

Enter

PALI - Palisade Bio, Inc.

Discounted Cash Flow Model Levered of Palisade Bio, Inc.(PALI), Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing,

photo-url-https://financialmodelingprep.com/image-stock/PALI.png

Palisade Bio, Inc.

PALI

NASDAQ

Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing oral therapies that target serious diseases associated with the breakdown of the mucosal barrier protecting the gastrointestinal tract. Its lead therapeutic candidate is LB1148, an oral liquid formulation of the digestive enzyme inhibitor that is intended to inhibit digestive enzyme activity and preserve gut integrity during intestinal stress resulting from reduced blood flow to the intestine, infections, or due to surgery. The company was founded in 2005 and is headquartered in Carlsbad, California.

4.35 USD

0.23 (5.29%)

page loading card
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep